| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000020283 |
| Receipt No. | R000023418 |
| Scientific Title | The role of TP53 gene analysis in EUS-guided FNA specimens for differential diagnosis of pancreatic ductal adenocarcinoma |
| Date of disclosure of the study information | 2015/12/20 |
| Last modified on | 2020/02/09 (Ver. 3) |
| Basic information | |||
| Public title | The role of TP53 gene analysis in EUS-guided FNA specimens for differential diagnosis of pancreatic ductal adenocarcinoma | ||
| Acronym | TP53 gene analysis in pancreatic ductal adenocarcinoma | ||
| Scientific Title | The role of TP53 gene analysis in EUS-guided FNA specimens for differential diagnosis of pancreatic ductal adenocarcinoma | ||
| Scientific Title:Acronym | TP53 gene analysis in pancreatic ductal adenocarcinoma | ||
| Region |
|
||
| Condition | ||
| Condition | pancreatic solid mass | |
| Classification by specialty |
|
|
| Classification by malignancy | Malignancy | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To evaluate the usefulness of TP53 gene analysis in EUS-guided FNA specimens from pancreatic masses. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | Explanatory |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Improvement of the diagnostic accuracy by TP53 gene analysis in EUS-guided FNA specimens from pancreatic solid masses |
| Key secondary outcomes | Development of predictive factors in therapeutics |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who underwent EUS-guided FNA of pancreatic masses. | |||
| Key exclusion criteria | Case whom no consent is obtained. | |||
| Target sample size | 160 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Nagoya City University Graduate School of Medical Sciences | ||||||
| Division name | Department of Gastroenterology and Metabolism | ||||||
| Zip code | |||||||
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467-8601, Japan | ||||||
| TEL | +81-52-853-8211 | ||||||
| yhori@med.nagoya-cu.ac.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Nagoya City University Graduate School of Medical Sciences | ||||||
| Division name | Department of Gastroenterology and Metabolism | ||||||
| Zip code | |||||||
| Address | 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya Japan | ||||||
| TEL | +81-52-853-8211 | ||||||
| Homepage URL | |||||||
| yhori@med.nagoya-cu.ac.jp | |||||||
| Sponsor | |
| Institute | Nagoya City University Graduate School of Medical Sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Pancreas Research Foundation of Japan |
| Organization | |
| Division | |
| Category of Funding Organization | Non profit foundation |
| Nationality of Funding Organization | Japan |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | |
| Address | |
| Tel | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 名古屋市立大学病院(愛知県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete |
|
||||||
| Date analysis concluded |
|
||||||
| Other | |
| Other related information | Samples are collected from subjects who participated in this study in Nagoya City University Hospital and research affiliated facilities.
Samples and clinical information without containing personal information are numbered and managed in Nagoya City University Hospital. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023418 |